Efficacy of fluoxetine for anorexia nervosa caused by chemotherapy in patients with cholangiocarcinoma
Conclusion:
The findings of this study will provide most recent evidence of fluoxetine for AN caused by chemotherapy in patients with cholangiocarcinoma.
Systematic review registration:
PROSPERO CRD42019131583.
Source: Medicine - Category: Internal Medicine Tags: Research Article: Study Protocol Systematic Review Source Type: research
More News: Alternative and Complementary Therapies | Anorexia | Anxiety | Bile Duct Cancer | Chemotherapy | China Health | Cholangiocarcinoma | Complementary Medicine | Databases & Libraries | Depression | Eating Disorders & Weight Management | Fluoxetine | Internal Medicine | Prozac | Science | Statistics | Study